Read this company snapshot
Daily valuation snapshot
Polyrizon Ltd. Ordinary Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $8.99
- Market capitalization (USD)
- $21,829,021.33
- Price / earnings (TTM)
- Not reported
- Price / book
- Not reported
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research PLRZ in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research PLRZ in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing PLRZ with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $8.99 |
| Market capitalization (USD) | $21,829,021.33 |
| Price / earnings (TTM) | Not reported |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read PLRZ's valuation metrics
Company size
Polyrizon Ltd. Ordinary Shares's recorded market capitalization is $21,829,021.33. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Polyrizon Ltd. Ordinary Shares with Aurora
Use the snapshot above to ask a specific question about PLRZ. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow PLRZ's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.